scispace - formally typeset
C

Clemens Sommer

Researcher at University of Mainz

Publications -  163
Citations -  8349

Clemens Sommer is an academic researcher from University of Mainz. The author has contributed to research in topics: AMPA receptor & Receptor. The author has an hindex of 41, co-authored 155 publications receiving 7380 citations. Previous affiliations of Clemens Sommer include University of Ulm & Heidelberg University.

Papers
More filters
Journal ArticleDOI

Revised definition of neuropathic pain and its grading system: an open case series illustrating its use in clinical practice.

TL;DR: This open case series of 5 outpatients demonstrates how the grading system can be applied, in combination with appropriate confirmatory testing, to diagnosis neuropathic conditions in clinical practice.
Patent

Methods of treating neurological conditions with hematopoeitic growth factors

TL;DR: In this paper, a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor was described. But this method was not suitable for the treatment of stroke patients.
Journal ArticleDOI

Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.

TL;DR: In this to date, largest series of ependymomas with YAP1‐MAMLD1 fusions, it is shown that they harbor characteristic histopathological, cytogenetic and imaging features, occur mostly in young girls under 3 years and are associated with good outcome.
Journal ArticleDOI

Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.

TL;DR: NBO and HBO decrease infarct size after thromboembolic ischemia only if recanalization is successful, and combining the two withThrombolysis seems promising.
Journal ArticleDOI

Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia.

TL;DR: The endocannabinoids AEA and PEA achieved a significant neuroprotective effect by reducing size of infarcted tissue after tMCAO, which may have the potential to treat acute stroke and exert neuroprotection through a variety of mechanisms.